Provided by Tiger Trade Technology Pte. Ltd.

Merus Labs

1.30
0.0000
Volume:- -
Turnover:- -
Market Cap:152.10M
PE:-16.25
High:1.30
Open:1.30
Low:1.30
Close:1.30
52wk High:1.33
52wk Low:0.7005
Shares:117.00M
Float Shares:97.31M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0800
ROE:--
ROA:--
PB:1.04
PE(LYR):- -

Loading ...

Company Profile

Company Name:
Merus Labs
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Merus Labs International Inc., a specialty pharmaceutical company, owns, markets, and distributes pharmaceutical products primarily in Europe and Canada. The company offers Elantan, Isoket, and Deponit nitrates for acute and chronic coronary artery disease; Sintrom for the treatment and prevention of thromboembolism diseases; Emselex/Enablex, for the treatment of overactive bladder syndrome; Surgestone and Provames for various health indications in women’s; Speciafoldine for macrocytic anemia; and Tredemine for tapeworm. It also provides Salagen for the treatment of symptoms of dry eye and dry mouth disorders, as well as for xerostomia following radiation therapy; Estraderm MX for the treatment of signs and symptoms of estrogen deficiency due to menopause, and for the prevention of accelerated postmenopausal bone loss; and Vancocin for the treatment of gastrointestinal tract bacterial infections. The company is headquartered in Toronto, Canada.